FDA approved a new rizatriptan orally disintegrating film, Rizafilm.
FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.
What is causing morning headaches? Good Housekeeping interview with Dr. Alex Feoktistov
https://www.goodhousekeeping.com/health/a36826630/morning-headaches-causes/?fbclid=IwAR1F5LJPTXXSWbekETSD4kDmHo2NKSPf6m8teTrVriXhmIhVtWW4PlZzPOo
You Might Also Enjoy...
FDA recently cleared Nerivio for preventive treatment of migraine
The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.
Telehealth: The Advantages of Telemedicine
Struggles to get to the clinic? Trying to reduce your exposure to COVID-19? Telehealth is safe and easy — receive quality care from anywhere.
If you live in Illinois, California, or Florida we could see you via our secure telehealth platform.
Recently FDA approved nasal spray for acute migraine treatment is coming to market.
FDA has approved a new nasal spray for acute treatment of migraine in adults.
Adolescent Migraine: Q & A with Dr. Feoktistov and Migraine.com
A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.
Advanced option in migraine management
Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.